Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Agentic enterprise app lifecycle optimization platform company Opkey today announced the launch of Opkey Design Studio, a suite of agentic artificial intelligence capabilities that extends its ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Design Pharmaceuticals, a company redesigning small molecule drug discovery, today announced the closing of a pre-series A round of $5 million, including an ...

The increase in the utilization of monoclonal antibodies as therapeutics over the past two decades has been remarkable, with over 80 mAbs approved for use. The quick pace of clinical studies and ...